Source link : https://www.newshealth.biz/health-news/pembrolizumab-boosts-survival-in-anaplastic-thyroid-cancer/
CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab to conventional multimodal therapy shows significant benefits in reducing the recurrence risk and improving survival in the rare, aggressive cancer. “The data are quite compelling at this point,” first author Maria E. Cabanillas, MD, of the University of Texas MD […]
Author : News Health
Publish date : 2024-11-05 11:09:23
Copyright for syndicated content belongs to the linked Source.
